Section Arrow
Quote
CRL.NYSE
- Charles River Laboratories International
Quotes are at least 15-min delayed:2024/05/20 16:17 EDT
Last
 223.06
+1.45 (+0.65%)
Day High 
223.18 
Prev. Close
221.61 
1-M High
244.56 
Volume 
468.79K 
Bid
210
Ask
246
Day Low
218.97 
Open
222.37 
1-M Low
220.37 
Market Cap 
11.42B 
Currency USD 
P/E 26.04 
%Yield 0 
10-SMA 230.52 
20-SMA 231.57 
50-SMA 246.28 
52-W High 275 
52-W Low 161.65 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
8.51/11.55
Enterprise Value
14.48B
Balance Sheet
Book Value Per Share
70.67
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
2.92B
Operating Revenue Per Share
81.84
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
EXASExact Sciences Corp51+0.62+1.23%-- 
DMTKDermTech0.3601-0.1394-27.91%-- 
GHGuardant Health24.77-0.59-2.33%-- 
OPKOPKO Health1.32--0.000%-- 
LABStandard BioTools2.58+0.01+0.39%-- 
Quotes are at least 15-min delayed：2024/05/20 16:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.